15 June, 2010, Lysaker, Norway: Primary insider, CEO in Pronova BioPharma ASA, Morten Jurs, bought 15 June 10,000 shares in the company.
The shares were bought at an average share price of NOK 14.10. Total number of shares held by Mr Jurs after the purchase is 15,000 in addition to the 459,375 shares held by Jurs AS, beneficially owned by Morten Jurs.